BIOA vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

BIOA

39.3
AI Score
VS
ZBIO Wins

ZBIO

67.3
AI Score

Investment Advisor Scores

BIOA

39score
Recommendation
SELL

ZBIO

67score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BIOA ZBIO Winner
Revenue 5.22M 1.00M BIOA
Net Income -48.35M -192.44M BIOA
Net Margin -925.7% -19244.3% BIOA
Operating Income -54.71M -185.01M BIOA
ROE -12.9% -77.9% BIOA
ROA -12.2% -27.4% BIOA
Total Assets 396.93M 701.69M ZBIO
Cash 73.96M 196.58M ZBIO
Current Ratio 17.19 9.93 BIOA
Free Cash Flow -43.66M -132.44M BIOA

Relative Price Performance (Last 90 Days)

BIOA 1M: -32.1% · 3M: -73.4% ZBIO 1M: -14.6% · 3M: +7.0%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -36.9%), weak momentum, RSI 25

RSI (14): 25.1 · Price: $6.61

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.9 · Price: $28.30

Fundamentals Snapshot

Metric BIOA ZBIO
Market Cap — —
Forward P/E -2.7 -6.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -1.0%
Gross Margin -7.5% -212.5%
Operating Margin -12.0% -77.7%
EPS -2.29 -10.00
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.